ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,709Medicare Part D Prescriptions Filled, Including Refills

Rank: 30 out of 789

$1.2M Total Retail Price of All Prescriptions

Rank: 50 out of 789

953 Patients Receiving at Least One Drug in Part D
90% Patients 65 Years and Older
23% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Indiana
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

3% of this provider’s 953 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

13% of this provider’s 953 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Indiana
AMLODIPINE BESYLATE 1,156 1,091 213 1 4
LEVOTHYROXINE SODIUM 1,119 1,033 183 2 1
FUROSEMIDE 754 725 146 3 7
OMEPRAZOLE 734 644 149 4 6
LISINOPRIL 697 647 137 5 3
SIMVASTATIN 676 611 145 6 5
METFORMIN HCL 569 493 120 7 9
HYDROCHLOROTHIAZIDE 497 455 112 8 14
ATORVASTATIN CALCIUM 497 467 117 8 8
WARFARIN SODIUM 492 481 58 10 10
PRAVASTATIN SODIUM 492 457 106 10 13
HYDROCODONE-ACETAMINOPHEN 491 398 117 S3 12 2
ALPRAZOLAM 386 331 78 B 13 18
METOPROLOL TARTRATE 362 327 83 14 11
METOPROLOL SUCCINATE 358 328 57 15 15
POTASSIUM CHLORIDE 355 336 73 16 16
TRAMADOL HCL 354 343 93 17 20
GLIMEPIRIDE 348 315 61 18 33
CLOPIDOGREL 337 332* 70 19 19
LOSARTAN POTASSIUM 337 300 67 19 17
ATENOLOL 301 286 66 21 21
LISINOPRIL-HYDROCHLOROTHIAZIDE 275 270* 55 22 36
ALLOPURINOL 266 253 50 23 32
CYMBALTA 265 227 46 24 30
SERTRALINE HCL 256 244 46 25 23
GABAPENTIN 256 198 50 25 12
ALENDRONATE SODIUM 233 233 47 27 35
LOSARTAN-HYDROCHLOROTHIAZIDE 206 201* 44 28 47
SYNTHROID 199 194* 32 29 39
CRESTOR 196 185 35 30 31
CARVEDILOL 191 176 37 31 22
PANTOPRAZOLE SODIUM 184 179* 41 32 26
FLUTICASONE PROPIONATE 173 141 60 33 43
TAMSULOSIN HCL 170 144 35 34 28
ZOLPIDEM TARTRATE 166 142 37 35 29
CITALOPRAM HBR 162 157* 29 36 24
NEXIUM 162 157* 33 36 34
DONEPEZIL HCL 147 147 23 38 27
ISOSORBIDE MONONITRATE ER 133 128* 27 39 48
LANTUS 133 102 22 39 49
CLONAZEPAM 122 90 20 B 41 57
MELOXICAM 121 110 30 42 37
TORSEMIDE 116 111* 20 43 130
JANUVIA 116 102 19 43 66
NAMENDA 115 115 14 45 25
PREDNISONE 112 96 43 46 40
SPIRONOLACTONE 110 105* 21 47 59
DIOVAN 107 102* 22 48 53
LYRICA 104 81 18 49 84
FENTANYL 104 <11 <11 S2 49 75
MIRTAZAPINE 102 102 18 51 52
FLUOXETINE HCL 99 75 18 52 45
KLOR-CON M20 97 92* 25 53 50
TRAZODONE HCL 90 78 20 54 41
PAROXETINE HCL 89 72 19 55 70
AMOX TR-POTASSIUM CLAVULANATE 86 68 57 56 112
CELEBREX 85 85 17 57 83
TRIAMCINOLONE ACETONIDE 84 79* 35 58 155
PROAIR HFA 83 64 36 59 44
VENLAFAXINE HCL ER 82 69 17 60 89
MONTELUKAST SODIUM 78 66 15 61 51
VERAPAMIL ER 73 68* 16 62 138
ESCITALOPRAM OXALATE 71 57 12 63 38
DILTIAZEM 24HR ER 71 <11 <11 63 103
NADOLOL 68 68 13 65 290
EVISTA 67 67 14 66 102
HUMALOG 66 41 13 67 91
DIAZEPAM 62 48 13 B 68 99
GLYBURIDE 60 <11 <11 R 69 146
CLONIDINE HCL 59 <11 <11 70 63
POLYETHYLENE GLYCOL 3350 58 58 23 71 56
LANTUS SOLOSTAR 58 40 17 71 71
TRIAMTERENE-HCTZ 57 52* 14 73 46
AGGRENOX 57 57 13 73 183
NITROSTAT 55 50* 37 75 206
BD ULTRA-FINE PEN NEEDLE 54 43 23 76 94
NIFEDIPINE ER 50 <11 <11 77 131
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 24, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.